skip to Main Content

The Accelerator Gazette Interviews Dr. Hossein Rahnama About Student Entrepreneurship

Ryerson University, one of MaRS Innovation’s 16 member institutions, has created the Digital Media Zone (DMZ) to give student entrepreneurs and researchers — or anyone connected with a great idea connected to their campus — the space they need to grow their ideas.

Dr. Hossein Rahnama, the DMZ’s research director and a Ryerson University professor, was interviewed this week by The Accelerator Gazette about Ryerson’s approach to accelerating and incubating technologies.

Continue Reading

University of Toronto: Snapshot of Toronto’s Entrepreneurship Scene

Toronto Skyline at Night
Toronto Skyline at Night.

The University of Toronto’s news site has posted a brief snapshot of Toronto’s entrepreneurial scene, highlighting the university’s historical and current innovative strengths.

Here’s a brief excerpt:

Entrepreneurs don’t have to be in Silicon Valley to become the next great business success story. Toronto now ranks fourth among the world’s top 25 start-up ecosystems, according to Start-up Genome, a project that maps the success rates of start-ups. Toronto ranks just behind Silicon Valley, New York City and London.

Continue Reading

OtoSim Inc. Makes a Sound Pitch on BNN

OtoSim listens to the Verdict on BNN's The Pitch
Louis Hui (far left) listens to the panel’s comments on BNN’s The Pitch.

OtoSim Inc., a MaRS Innovation spin-off company, made its debut on Business News Network’s The Pitchon June 1, 2012.

Louis Hui, OtoSim’s business development manager, had 90 seconds to pitch OtoSim™ — an integrated educational system that dynamically and interactively teaches how to accurately diagnose ear diseases — to The Pitch’s panel of financiers and experts.

Continue Reading

MaRS Innovation Forms Strategic Drug-Development Partnership with NovoTek Therapeutics Inc. in China

ScarX logoMaRS Innovation (MI), The Hospital for Sick Children (SickKids) and NovoTek Therapeutics Inc. (NovoTek)  have announced a strategic partnership to co‐develop, and bring to the Chinese market, a novel therapeutic cream aimed at reducing scar formation post surgery.

This project was covered in The Globe and Mail on May 7, 2012.

Continue Reading

ApneaDX Inc: A Medical Device to Accurately Diagnose Sleep Apnea at Home

ApneaDX Corporate LogoMaRS Innovation and the University Health Network‘s Toronto Rehabilitation Institute have collaborated to bring a new technology to market that accurately diagnoses sleep apnea at the patient’s home.

Sleep apnea is a medical disorder that is gaining increasing recognition as a major health issue. It is estimated that six to eight per cent of the world’s population suffer from the disease, but 85 per cent are undiagnosed.

Undiagnosed sleep apnea is estimated to cause $3.4 billion in additional medical costs in the US.

Continue Reading

Xagenic Raises $10 million in Series A Financing

TORONTO (January 30, 2012) – Xagenic Inc., a start-up company created by Dr. Shana Kelley, in partnership with MaRS Innovation, today reached a significant milestone by successfully completing series A financing totaling $10 million.

The financing comes from sources from the private and public sector including CTI Life Sciences Fund L.P., Qiagen N.V. and the Ontario Capital Growth Corporation through its Emerging Technologies Fund.

Continue Reading
Back To Top